Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
10/2005
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050226844 Valency platform molecules comprising carbamate linkages
10/13/2005CA2561400A1 Chemical process and new crystalline form
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/12/2005EP1583738A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia
10/12/2005EP1201235B1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
10/12/2005EP0794774B1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
10/12/2005CN1681936A Process for producing optically active erythro 3-cyclohexylserines
10/12/2005CN1681780A Biological low-molecular weight derivatives
10/12/2005CN1681772A Succinic acid semi-amides as anti-corrosives agents
10/12/2005CN1681771A 4-(3, 3-dihalo-allyloxy)phenoxy alkyl derivatives
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1680371A Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
10/12/2005CN1680308A New 3-aryl-2-hydroxypropionic acid derivative I
10/12/2005CN1680298A Material and intermediate for trifluoromethyl-substituted spirocyclic ketoenols
10/12/2005CN1680297A New process for the synthesis of (7-methoxy-1-naphthyl)acetonitrile and its application in the synthesis of agomelatine
10/12/2005CN1680296A New process for the synthesis of (7-methoxy-1-naphthyl)acetonitrile and application in the synthesis of agomelatine
10/12/2005CN1680295A New process for the synthesis of (7-methoxy-3, 4-dihydro-1-naphthalenyl)acetonitrile and its application in the synthesis of agomelatine
10/12/2005CN1680285A Industrial production of natural capsaicin crystal by molecular distilling and washing method
10/12/2005CN1680284A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/12/2005CN1680273A Process for producing n-(1-(2, 4-dichlorophenyl)ethyl)-2- cyano-3, 3-dimethylbutanamide
10/12/2005CN1680272A C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/11/2005US6953865 reacting (R)- or (S)- nitryloxycarnitine with sodium azide; hydrogenation to the intermediate azidocarnitine of same configuration; no isolation
10/11/2005US6953798 compounds are able to inhibit binding of alpha 4 integrins to their ligands and are of use in prophylaxis and treatment of immune or inflammatory disorders
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092937A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/06/2005WO2005092848A1 Novel perfluoroalkyl hydrophobic and oil-repellent surfactants derived from substituted amides, preparation and use thereof
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092839A1 A novel catalytic process for the production of 3,3', 4,4'-tetraminobiphenyl
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092316A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005WO2005092314A1 4-oxo-fenretinide, administered alone and in combination with fenretinide, as preventive and therapeutic agent for cancer
10/06/2005WO2005092305A2 Compounds for treating aids and other diseases
10/06/2005WO2005074897A3 Formulation auxiliary agents (aminopropanoic acid derivative) in cosmetic or dermatological preparations
10/06/2005US20050222524 Apparatus and method for applying variable localized pressure to the human body
10/06/2005US20050222458 Catalytic dehydration and amidation of alpha or beta hydroxycarboxylic acids; efficient, simple, mild reaction conditions; water tolerance
10/06/2005US20050222256 Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl)cyclohexyl] carbonyl]glycine
10/06/2005US20050222242 Process for preparing a dipeptidyl peptidase IV inhibitor and intermediates employed therein
10/06/2005US20050222213 Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222089 taxane is prepared by esterifying an appropriate baccatin carrying a C-13 hydroxyl functional group with an acid derivative and is obtained by controlled saponification
10/06/2005US20050221389 Organic reactions with CO generating materials
10/06/2005CA2560922A1 Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
10/06/2005CA2560526A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005CA2560388A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1581510A2 1-aryl-2-hydroxyethyl amides as potassium channel openers
10/05/2005EP1581480A1 Cyclopentil-substituted glutaramide compounds as endopeptidasev inhibitors
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581467A2 Ligands for metals and improved metal-catalyzed processes based thereon
10/05/2005EP1581205A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
10/05/2005EP1226107B1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678567A Phenyl benzamides
10/05/2005CN1678566A Novel composition containing acyl group
10/05/2005CN1678565A Synthesis of N-vinyl formamide
10/05/2005CN1676514A 1-di-ester-base-3-alkyl imidazo ion liquid and its preparing method
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/05/2005CN1221504C Perfluoroisopropylbenzene derivatives
10/04/2005US6951884 Fluorobenzamides and uses thereof
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
10/04/2005US6951844 substituted 5-phenyl-2-naphthols; metabolic disorders
10/04/2005CA2094397C Homobifunctional agents for coupling enzymes and the like to antibodies and the like
09/2005
09/29/2005WO2005090285A1 Novel crystal of triterpene derivative
09/29/2005WO2005090284A1 Non-glycosylated/non-glycosidic/non-peptidic small molecule psgl-1 mimetics for the treatment of inflammatory disorders
09/29/2005WO2005090268A1 Radiolabeled 3-[3-(benzoyl-amido)benzyloxy]aspartic acid derivative and method of producing the same
09/29/2005WO2005089354A2 Apparatus and method for applying variable localized pressure to the human body
09/29/2005US20050215823 Novel catalytic process for the production of 3,3', 4,4'-tetraminobiphenyl
09/29/2005US20050215819 Method of producing an amide
09/29/2005US20050215799 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215731 Process for production of molecular devices
09/29/2005US20050215598 Phenylalanine derivatives
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215435 Phenylalanine derivatives as herbicides
09/29/2005DE10218595B4 Verfahren zur Herstellung von hochreinem kristallinen Trichloracetamid aus Trichloracetylchlorid A process for the production of high purity crystalline trichloroacetamide of trichloroacetyl chloride
09/29/2005CA2560767A1 Novel crystal of triterpene derivative
09/28/2005EP1580187A1 Apoptogenic and antiproliferative analogs of ceramide
09/28/2005EP1578898A2 Nad synthetase inhibitors and uses thereof
09/28/2005EP1578719A2 Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof
09/28/2005EP1474381B1 Phenylalanine derivatives as herbicides
09/28/2005EP1082292B1 Control of pain with endogenous cannabinoids
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1673213A Process of extracting capsicine crystal from chili
09/28/2005CN1220675C Process and appts. for prepn. of sulfurized methylacryloyl amine
09/28/2005CN1220520C Inhibition of 2, 3-dihydrogen-indone to 26S and 20S prolease
09/27/2005US6949663 Multilayer; anticoagulant
09/27/2005US6949568 Such as N-(2-(4-(3-phenyl-4-methoxyphenyl)aminophenyl)ethyl)-2-hydroxy-2-(3 -hydroxymethyl-4-hydroxyphenyl)ethylamine; for treatment of chronic obstructive pulmonary disease
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005CA2327056C Phosphine reduction of azides to amides
09/22/2005WO2005087713A1 Amide compound, pharmaceutical composition and rxr function control agent
09/22/2005WO2005087712A1 Synthesis of n-vinyl formamide
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087709A1 4-t-butylgabapentin and its synthesis
09/22/2005WO2005087700A2 Bisphenyl compounds useful as vitamin d3 receptor agonists
1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 289